Vanguard Amends DaVita Stake, Remains Passive Investor

TL;DR

**Vanguard still owns a big chunk of DaVita, but they're just holding, not trying to run the show.**

AI Summary

The Vanguard Group filed an amended Schedule 13G/A on February 13, 2024, indicating its ownership of DaVita Inc. common stock as of December 29, 2023. This filing, Amendment No. 13, updates previous disclosures about Vanguard's passive investment in DaVita, a healthcare company specializing in kidney dialysis. This matters to investors because Vanguard is a major institutional investor, and its continued significant, albeit passive, stake signals a long-term belief in DaVita's stability and potential, which can influence other investors' perceptions of the stock.

Why It Matters

This filing confirms Vanguard's continued substantial, yet passive, ownership in DaVita, signaling institutional confidence in the company's long-term prospects.

Risk Assessment

Risk Level: low — This filing is routine and indicates a passive investment, posing minimal direct risk to current or prospective shareholders.

Analyst Insight

Investors should view this as a routine update from a major passive institutional holder. It doesn't signal any immediate change in DaVita's operational or strategic direction, but rather confirms continued long-term institutional interest. No urgent action is required based solely on this filing.

Key Players & Entities

• The Vanguard Group (company) — reporting person and institutional investor
• DaVita Inc. (company) — subject company, a healthcare provider
• December 29, 2023 (date) — date of event requiring the filing
• February 13, 2024 (date) — filing date of the SC 13G/A
• Amendment No. 13 (number) — identifies this as the thirteenth amendment to Vanguard's Schedule 13G filing for DaVita

FAQ

From the Filing

0001104659-24-020735.txt : 20240213 0001104659-24-020735.hdr.sgml : 20240213 20240213170242 ACCESSION NUMBER: 0001104659-24-020735 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-47431 FILM NUMBER: 24628014 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VANGUARD GROUP INC CENTRAL INDEX KEY: 0000102909 ORGANIZATION NAME: IRS NUMBER: 231945930 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: PO BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482-2600 BUSINESS PHONE: 6106691000 MAIL ADDRESS: STREET 1: PO BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482-2600 SC 13G/A 1 tv0735-davitainc.htm SCHEDULE 13G/A davitainc SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer:  DaVita Inc Title of Class of Securities:  Common Stock CUSIP Number:  23918K108 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule 13d-1(c) ☐ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on the following page(s))     13G CUSIP No.:  23918K108 1.  NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON The Vanguard Group - 23-1945930 2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP A.  B.  X 3.  SEC USE ONLY 4.  CITIZENSHIP OF PLACE OF ORGANIZATION Pennsylvania (For questions 5-8, report the number of shares beneficially owned by each reporting person with:) 5.  SOLE VOTING POWER 0 6.  SHARED VOTING POWER 72,357 7.  SOLE DISPOSITIVE POWER 6,085,762 8.  SHARED DISPOSITIVE POWER 234,978 9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,320,740 10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES N/A 11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.92% 12.  TYPE OF REPORTING PERSON IA     SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Act of 1934 Item 1(a) - Name of Issuer: DaVita Inc Item 1(b) - Address of Issuer's Principal Executive Offices: 2000 16th Street Denver, CO 80202-7198 Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930 Item 2(b) – Address of